Mitsutaka Shoji
Overview
Explore the profile of Mitsutaka Shoji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
285
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamura M, Shoji M, Fujita K, Nakamura S, Takahashi Y, Suzuki Y, et al.
J Med Case Rep
. 2017 Nov;
11(1):324.
PMID: 29145887
Background: The clinical characteristics of infective endocarditis include the presence of predisposing cardiac disease, a history of illegal drug use, and high morbidity in the elderly. Only a few cases...
2.
Shoji M, Cui L, Iizuka R, Komoto A, Neoh H, Watanabe Y, et al.
Antimicrob Agents Chemother
. 2011 Jun;
55(8):3870-81.
PMID: 21628539
Vancomycin-intermediate Staphylococcus aureus (VISA) is generated from vancomycin-susceptible Staphylococcus aureus by multiple spontaneous mutations. We previously reported that sequential acquisition of mutations in the two-component regulatory systems vraSR and graRS...
3.
An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus
Cui L, Isii T, Fukuda M, Ochiai T, Neoh H, Camargo I, et al.
Antimicrob Agents Chemother
. 2010 Sep;
54(12):5222-33.
PMID: 20837752
We have previously reported the establishment of a Staphylococcus aureus laboratory strain, 10 3d1, having reduced susceptibility to daptomycin and heterogeneous vancomycin-intermediate S. aureus (VISA) phenotype. The strain was generated...
4.
Cui L, Neoh H, Shoji M, Hiramatsu K
Antimicrob Agents Chemother
. 2009 Jan;
53(3):1231-4.
PMID: 19124662
We describe here the genetic analysis of a vancomycin-susceptible Staphylococcus aureus (VSSA) strain, Mu50Omega, a strain related to vancomycin-intermediate S. aureus (VISA) strain Mu50. Using a combination of Mu50Omega whole-genome...
5.
Sakurai Y, Furuta S, Sunagawa R, Tonomura S, Inaba K, Shoji M, et al.
Gan To Kagaku Ryoho
. 2007 Oct;
34(10):1581-7.
PMID: 17940372
Orotate phosphoribosyltransferase (OPRT, EC 2.4.2.10), a key enzyme that catalyzes one of the primary first-step phosphorylation processes of fluoropyrimidine, has recently been recognized as an important factor that primarily determines...
6.
Sakurai Y, Masui T, Yoshida I, Tonomura S, Shoji M, Nakamura Y, et al.
World J Surg
. 2007 Jul;
31(11):2150-7.
PMID: 17653789
Background: Although perioperative immune-enhancing enteral formula (IEEF) is effective to decrease the rate of infectious complications, it is not clear whether perioperative use of IEEF decreases the incidence of postoperative...
7.
Sakurai Y, Yoshida I, Tonomura S, Inaba K, Shoji M, Nakamura Y, et al.
Gan To Kagaku Ryoho
. 2006 Aug;
33(8):1111-8.
PMID: 16912530
Although orotate phosphoribosyltransferase (OPRT EC 2.4.2.10) is a key enzyme related to the first-step activation process of 5-fluorouracil, and therefore it has been shown to be an important enzyme that...
8.
Sakurai Y, Sakamoto K, Sugimoto Y, Yoshida I, Masui T, Tonomura S, et al.
Cancer Sci
. 2006 Jun;
97(6):492-8.
PMID: 16734727
A number of enzymes have been shown to be involved in the process of activation and/or degradation of 5-fluorouracil (5-FU), and are potential candidates for predicting chemosensitivity to 5-FU. Among...
9.
Sakurai Y, Yoshida I, Tonomura S, Inaba K, Shoji M, Nakamura Y, et al.
Gan To Kagaku Ryoho
. 2006 Apr;
33(4):487-92.
PMID: 16612158
Orotate phosphoribosyltransferase (OPRT EC 2.4.2.10) is a key enzyme related to the first-step phosphorylation process of 5-fluorouracil. We have recently developed an ELISA system to measure OPRT levels in cancerous...
10.
Uyama I, Sakurai Y, Komori Y, Nakamura Y, Shoji M, Tonomura S, et al.
Gan To Kagaku Ryoho
. 2005 Sep;
32(9):1247-50.
PMID: 16184918
Many laparoscopic surgeries for gastric cancer are presented, including D 2 lymphadenectomy, gastrectomy with preservation of vagus nerve and intracorporeal anastomosis after some gastrectomies. The great advances in laparoscopic treatments...